Back
Arcturus Therapeutics Holdings Stock Predictions
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
44
ARCT
Arcturus Therapeutics Holdings
Last Price:
21.02
Seasonality Move:
-4.29%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Arcturus Therapeutics Holdings Stock Forecast
- Over the next 52 weeks, Arcturus Therapeutics Holdings has on average historically risen by 17.6% based on the past 11 years of stock performance.
- Arcturus Therapeutics Holdings has risen higher in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
-
Is Arcturus Therapeutics Holdings Stock Undervalued?
The current Arcturus Therapeutics Holdings [ARCT] share price is $21.05. The Score for ARCT is 44, which is 12% below its historic median score of 50, and infers higher risk than normal. - ARCT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Arcturus Therapeutics Holdings Stock Go Up Next Year?
- Over the next 52 weeks, Arcturus Therapeutics Holdings has on average historically risen by 17.6% based on the past 11 years of stock performance.
Arcturus Therapeutics Holdings Stock Rating
Sell
44
Arcturus Therapeutics Holdings (ARCT)
is a Sell
Is Arcturus Therapeutics Holdings overpriced?
- Arcturus Therapeutics Holdings has risen higher in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
Arcturus Therapeutics Holdings Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
arcturusrx.com
52-Week Data
52-Week High:
45.00
52-Week Low:
17.52
Prediction Charts
Market Cap:
569.24M
Price in USD:
21.05
Volume:
264.85K
Beta:
2.52
Technical Analysis
SMA50:
21.26
SMA100:
25.36
SMA200:
29.11
52-Wk Change:
-24.47%
Stock Predictions
-
Is Arcturus Therapeutics Holdings stock public?
Yes, Arcturus Therapeutics Holdings is a publicly traded company. -
What is the Arcturus Therapeutics Holdings stock quote today?
The Arcturus Therapeutics Holdings stock price is 21.05 USD today. -
How to buy Arcturus Therapeutics Holdings stock online?
You can buy Arcturus Therapeutics Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Aug-30 | 21.07 | 21.12 | 21.35 | 20.59 |
| Sep-3 | 21.02 | 19.38 | 21.96 | 19.20 |
| Sep-4 | 19.47 | 19.06 | 19.98 | 18.94 |
| Sep-5 | 19.06 | 18.82 | 19.31 | 18.69 |
| Sep-6 | 18.64 | 18.65 | 18.91 | 18.11 |
| Sep-9 | 18.75 | 19.00 | 19.25 | 18.55 |
| Sep-10 | 19.05 | 19.76 | 19.85 | 18.92 |
| Sep-11 | 19.58 | 20.99 | 21.02 | 19.25 |
| Sep-12 | 20.95 | 19.91 | 21.00 | 19.53 |
| Sep-13 | 20.22 | 20.75 | 20.87 | 19.97 |
| Sep-16 | 20.96 | 20.61 | 21.41 | 20.10 |
| Sep-17 | 21.02 | 21.01 | 21.99 | 20.62 |
| Sep-18 | 20.80 | 20.55 | 21.55 | 20.05 |
| Sep-19 | 21.23 | 21.05 | 21.70 | 20.94 |
Arcturus Therapeutics Holdings Earnings
Arcturus Therapeutics Holdings Earnings Report: Per Share Arcturus Therapeutics Holdings Earnings Q1 Q2 Q3 and Q4 last year and next year.
Arcturus Therapeutics Holdings Forecast Revenue Growth
Arcturus Therapeutics Holdings Stock Analysis: Historical quarterly revenues per share for Arcturus Therapeutics Holdings and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.60 per share, an increase next quarter of $1.49 per share, a decrease this year of $0.50 per share, and an increase next year of $1.47 per share.
* Arcturus Therapeutics Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.